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Part VI:  
In Vitro Fermentation Models:  
General Introduction 
 
The human colonic microbiota is a dense and highly diverse microbial community that 
contributes in many ways to host health, including through the recovery of metabolic 
energy from non-digestible dietary components and the maintenance of intestinal 
homeostasis (Bäckhed et al. 2012 ; Hooper et al. 2012 ). The evaluation of gut 
microbial composition and diversity, and its impact on food digestion, by either culture 
dependent or culture independent (e.g. metagenomics) methodologies has focused 
primarily on fecal samples, which are considered to be representative of the distal large 
intestine. These studies, however, do not provide insights into dynamic microbial 
processes and functionality or digestion at their locations in the gut. In vitro 
fermentative models are considered excellent tools to allow the screening of a large 
number of substances, ranging from dietary ingredients to pathogens, drugs and toxic 
or radioactive compounds, to assess how they alter and are altered by gastrointestinal 
environments and microbial populations without ethical constraints. In vitro models vary 
from batch incubations using anaerobic conditions and dense fecal microbiota to more 
complex continuous models involving one or multiple connected, pH-controlled 
chemostats inoculated with fecal microbiota and representing different parts of the 
human colon (Venema and Van den Abbeele 2013 ). The common purpose of in vitro 
gut fermentation models is to cultivate a complex intestinal microbiota under controlled 
environmental conditions for carrying out microbial modulation and metabolism studies. 
Selection of the appropriate model depends on the study objectives and the 
advantages and limitations exhibited by each type of system (Payne et al. 2012 ). Part 
VI describes a number of these in vitro gut fermentation models. 
 
Batch Fermentation Models 
Batch-type simulators represent models ranging from closed bottles used to grow defi 
ned (single or mixed) bacterial strains to controlled reactors inoculated with fecal 
microbiota suspensions. These models usually operate under anaerobic conditions and 
studies proceed over short-term periods. They are used to study the effects of 
substrates on the physiology and biodiversity of intestinal microorganisms, and vice 
versa. The impact on the microbiota is evaluated by molecular quantitative and 
qualitative techniques and the impact on metabolic activity is assessed by evaluating 
the formation of short chain fatty acids (SCFA) or other metabolites. These models are 
appropriate to check for inter-individual variability in the response to a particular 
bioactive or agent or for comparison of the consequences of exposure to different 
sources or doses of compounds. In addition, as noted, they provide a fi rst assessment 
of the types of microbial metabolites formed and helps to elucidate the pathways 
involved (see Chap. 25). On the other hand, they are limited by substrate depletion and 
the accumulation of the end products of microbial metabolism that alter the conditions 
in the batch away from the microbial balanced starting point, thus affecting the in vivo 
relevance in longer simulations. 
 
Dynamic Fermentation Models  
Several dynamic fermentation models have been developed in recent years with the 
purpose to establish in vitro a relatively stable microbial ecosystem under 
physiologically relevant colon conditions. Continuous multistage and single-
fermentation models are useful for longer-term experiments needed to evaluate the 
spatial and temporal adaptation of the colonic microbiota to dietary compounds and the 
microbial metabolism of dietary ingredients. Most of the dynamic multistage-
fermentation models are based on the Reading model firstly described by Gibson et al. 
(1988).  
The model consists of three vessels of increasing size, aligned in series such that a 
sequential feeding of growth medium occurs, mimicking the conditions of proximal, 
transverse and distal colon.  
The operating conditions included setting of pH for the three vessels at 5.5, 6.2, and 
6.8, respectively; values which were calculated using measurements made on colonic 
contents taken from sudden death victims (Macfarlane et al. 1992). Thus, the first 
vessel has a high availability of substrate, representing a rapid bacterial growth rate 
and is operated at an acidic pH, similar to events in the proximal colon. In contrast, the 
final vessel resembles the neutral pH, slow bacterial proliferation rate and low substrate 
availability which is characteristic of more distal regions. The authors also developed a 
nutritious medium that has been extensively used in both batch and dynamic 
fermentation models. The medium consists of protein substrates (casein and peptone), 
complex carbohydrates (pectin, xylan, arabinogalactan and resistant starches) that are 
not digested by gastrointestinal enzymes, and a mixture of salts and vitamins (Gibson 
et al. 1988). The viability of the in vitro gut microbiota is dependent on the continuous 
replenishment of nutrients and the control of physiological temperature and anaerobic 
conditions. The control of these factors allows the establishment of steady-state 
conditions, with respect to both microbial composition and metabolic activity, whereas 
the control of defi ned pH values, downstream nutrient limitations and retention times in 
the different vessels allows a region- specific differentiation of the colonic microbiota in 
terms of metabolic activity and microbial communities. Anaerobic conditions are usually 
reached through continuous CO2 or N2 flushing of the headspace. Two representative 
three-stage fermentation models are described in Chaps. 27 (SHIME) and 28 (SIMGI). 
Continuous single-stage fermentation models are often designed to simulate the 
proximal colon conditions and to reproduce its metabolic activity. The most 
sophisticated dynamic model is represented by the multiple-component continuous 
system TIM-2 (Minekus et al. 1999). The model reproduces the peristaltic mixing of 
proximal colonic luminal content as well as the absorption of water and fermentation 
products (see Chap. 26). A comparison of the TIM-2 and the multistage- fermentation 
model SHIME (see Chap. 27) to study long-chain arabinoxylans as potential prebiotics 
has demonstrated that both models similarly revealed a compound- specific modulation 
of prebiotics in terms of short chain fatty acid production and stimulation of specific Bifi 
dobacterium species (Van den Abbeele et al. 2013). The simulation of the human distal 
gut environment by maintaining neutral pH conditions and a constant culture volume 
has been recently described by McDonald et al. (2013) using a twinvessel single-stage 
chemostat model. Moreover, recent developments are addressing the construction of 
single-stage models simulating the ileum microbiota (Venema and Van den Abbeele 
2013). The ileum is the region harboring the highest bacterial population within the 
small intestine due to its slower peristalsis and lower concentrations of digestive 
enzymes and bile. This type of model can be of special utility to demonstrate bacterial 
competition against food-borne pathogens and toxin production (Ceuppens et al. 
2012). 
 
Inoculation of Gut Fermentation Models  
The inoculation and colonization of in vitro fermentation systems influences the 
reproducibility of the studies and constitute a challenge of the models (Payne et al. 
2012). Fermenters are usually inoculated with a liquid fecal suspension from an 
individual or pooling stools from several subjects. In the last case, the fecal samples 
are used to inoculate a fed-batch fermenter to produce a standardized inoculum that is 
stored frozen. Cinquin et al. (2004) developed an immobilization process for the 
entrapment of fecal microbiota in mixed xanthan–gellan gum gel beads to reach high 
cell densities and to maintain the microbial diversity over long time continuous colonic 
fermentations.  
 
The model has recently been updated into the model PolyFermS where it is possible to 
stably and reproducibly cultivate complex intestinal communities in multiple reactors 
allowing studying in parallel the impact of different treatments compared to a control 
reactor (Zihler Berner et al. 2013). In order to facilitate the reproducibility of 
experiments, recent developments are addressing the inoculation of fermentation 
models with defined populations of human gut microorganisms represented by 
common saccharolytic and amino acid- fermenting populations in the large intestine 
(Newton et al. 2013). 
 
Host-Gut Microbiota Interaction  
A major drawback of gut fermentation models is the limitations for simulating the host 
functionality. The combination of fermentation models and intestinal cell cultures 
represent a common approach to reproduce in vitro the host responses. These studies 
have been usually performed with colon epithelial cell cultures and/or immune cells to 
evaluate adherence, cytokine production and gene expression, among others (Venema 
and Van den Abbeele 2013). Additional tools that have improved modeling of the 
physiological colonic conditions are the incorporation in the reactors of a mucosal 
environment able to differentiate between the luminal microbiota and the microbial biofi 
lms adhering to the colonic epithelium (Macfarlane et al. 2005; Van den Abbeele et al. 
2012). The Host-Microbiota Interaction (HMI) module is a recently developed device 
adapted to the SHIME model that allows long-term studies of a complex microbial 
community colonizing a mucus layer, while being co-cultured microaerophilically (up to 
48 h) in the presence of shear forces and a monolayer of enterocyte human cells 
(Marzorati et al. 2014). This combination of in vitro models represents an 
approximation to the conceptualized ideal experimental model for the study of host-gut 
microbiota interactions described by Fritz et al. (2013). These authors claim that the 
ideal model should include epithelial cells, complex gut microbiota, 
anaerobic/microaerophilic conditions, a mucus layer and physiological conditions of pH, 
fl uid retention times and dissolved O 2 concentrations. The progress made in 
developing in vitro fermentation models able to closely mimic the gut microbial 
environment and the increasing knowledge regarding microbial populations and host-
gut microbiota interactions can offer remarkable insights into gut microbiota functions. 
Moreover, ongoing studies would allow the development of well-defined mixtures of 
microorganisms that retain a high level of diversity and encompass key functions 
required for healthy intestinal homeostasis in an approach coined “microbial ecosystem 
therapeutics” by Petrof et al. (2013). 
 
 
 
